News Releases

IBBR Researchers Awarded $850K from NSF to Study How Plants Defend Against Fungal Invasion (Rockville, MD, February 25, 2020) Researchers at the Institute for Bioscience and Biotechnology Research (IBBR) recently received $850K from the National Science Foundation (NSF) to advance our understanding of how fungi like powdery mildew infect plants including food source crops, and how plants fight back. The will support advances in sustainable farming by revealing the mechanisms that fungi use to infect plants.
Kunal Kundu Receives Outstanding Graduate Assistant Award February 13, 2020 - Please join us in congratulating Kunal Kundu for receiving an Outstanding Graduate Assistant Award from the UMCP Graduate School.
IBBR Request for Proposals (RFP): GMP Biomanufacturing Facility Available - Rockville, Maryland The Institute for Bioscience and Biotechnology Research (IBBR) is accepting proposals to lease a bio-manufacturing facility configured to produce biologicals under cGMP conditions in compliance with FDA requirements for phase I/II clinical trials. The facility is also equipped to perform process development research, pre-clinical manufacturing for material necessary to conduct IND-enabling toxicology studies, proof of concept (POC) studies, and process demonstration in advance of Good Manufacturing Practices (GMP) manufacturing.
IBBR-REFI Travel Fellowship: Spring 2020 Application Open February 7, 2020 - The IBBR-REFI Travel Fellowship supports UMCP graduate students and postdoctoral researchers working on projects aligned with the institutes' shared missions.
Fighting Acne: A New Approach Sourced From Viruses IBBR researchers receive funding to explore the use of viral proteins against the bacteria that cause acne (Rockville, MD, February 4, 2020) IBBR Fellow Dr. Daniel Nelson received a Technology Assessment award from the Maryland Innovation Initiative (MII) to support development of a new, easy-to -use, topical treatment modality for acne based on his endolysin research.
Revealing the Key to Hypervirulent C. difficile Toxin Delivery January 31, 2020 - A large team of researchers, led by IBBR Associate Director David Weber, recently published the structure of a toxin from a hypervirulent C. difficile strain. Their work is highlighted on the cover of Proceedings of the National Academies of Sciences USA (PNAS).
IBBR Launches BioNEXUS Magazine December 11, 2019 -- IBBR is pleased to share the inaugural issue of a new magazine, BioNEXUS.
IBBR Researchers Receive $1.1M from FDA and NIIMBL to Support Biomanufacturing Innovation Yu lab developing novel analytical technologies for biopharmaceutical products in collaboration with industry partners Merck and Pfizer (Rockville, MD, November 19, 2019) IBBR Fellow Dr. Bruce Yu recently received two awards totaling $1.1M from the FDA and NIIMBL to advance the development of analytical methods for characterizing complex drugs and vaccines.
Congratulations to Tsega Solomon for a Successful Dissertation Defense November 11, 2019 -- Please join us in congratulating Tsega Solomon for successfully defending her dissertation, “Protein fold switching: investigating the mechanism of αβ-plait to 3α fold interconversion."
Robert Brinson and Kyle Anderson Receive MML Accolades October 9, 2019 - IBBR Fellow Robert Brinson and NIST Research Chemist Kyle Anderson were honored last month at the NIST Molecular Measurement Laboratory's 2019 Accolades Gala.